AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

RecruitingPhase 3Ages 40 Years - anyAllFirst Affiliated Hospital of Wannan Medical Colle…
💬

In plain words

What the trial is, and whether it could suit you

This study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1.40 years or older than 40 years; 2.Ischemic stroke or transient ischemic attack (TIA); 3.Within 7 days from onset to randomization; 4.Main intracranial or extracranial arteries supplying the ischemic event region are narrowed by more than 50%; 5.Informed consent signed. Exclusion Criteria: 1. Presumed cardiac source of embolus, such as atrial fibrillation, prosthetic cardiac valve, endocarditis or patent foramen ovale; 2. Stroke/TIA due to arterial dissection, angioplasty, or vascular surgery; 3. Usage of probucol within 30 days before randomization; 4. Known allergy or sensitivity or intolerance to probucol; 5. Myocardial disease within the past 30 days, including myocardial infarction, myocarditis; 6. With ventricular tachycardia, bradycardia, tip-twist ventricular tachycardia; 7. With Q-Tc interval prolongation, or currently using drugs that may cause Q-Tc interval prolongation (male Q-Tc\>450ms, female Q-Tc\>470ms); 8. Cardiac syncope or unexplained syncope; 9. Impaired hepatic (ALT or AST \> twice the upper limit of normal range) or kidney (creatinine exceeding 1.5 times of the upper limit of normal range or eGFR less than 50 ml/min) function at randomization; 10. Anemia (haemoglobin \<10g/dL), thrombocytopenia (platelet count \<100×109/L) or leucopenia (white blood cell \<3×109/L) at randomization; 11. Planned surgery or interventional treatment requiring cessation of the study drug during the study; 12. Participating in another clinical trial with an investigational drug or device concurrently or during the last 30 days; 13. Pregnant or lactating women; Pregnant, currently trying to become pregnant, or of child-bearing potential and not using birth control; 14. Severe non-cardiovascular comorbidity with a life expectancy of less than 1 years; 15. Serious drug or alcohol abuse in the past 1 year; 16. Inability to understand and/or follow research procedures due to mental, cognitive, or emotional disorders, or to be an unsuitable candidate for the study for any other considered by the investigator.
💊

What it tests

  • Probucol
  • Placebo probucol
📍

Where

1 site
The First Affliated Hospital of Wannan Medical College
Wuhu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy